Close Menu

NEW YORK — Point-of-care test developer Chembio Diagnostics said today that it has closed a $20 million term loan with an affiliate of healthcare investor Perceptive Advisors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.